Ernexa Therapeutics (ERNAW) Shares Outstanding (2010 - 2026)

Ernexa Therapeutics has reported Shares Outstanding for 17 years, with the latest figure at $1.2 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 647.44% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (up 647.44% YoY), and the FY2025 full-year result was $156000.0, changed 0.0% from the prior year.
• Shares Outstanding for Q1 2026 stood at $1.2 million, up from $156000.0 in the prior quarter.
• The five-year high for Shares Outstanding was $7.8 million in Q3 2025, with the low at $139000.0 in Q1 2025.
• Historically, Shares Outstanding has averaged $2.1 million across 5 years, with a median of $361000.0 in 2023.
• Annual changes were most pronounced in 2022 — Shares Outstanding tumbled 99.62% — and 2023, when it surged 3367.95%.
• Ernexa Therapeutics' Shares Outstanding stood at $5.1 million in 2022, then slumped by 92.96% to $361000.0 in 2023, then slumped by 56.79% to $156000.0 in 2024, then changed by 0.0% to $156000.0 in 2025, then surged by 647.44% to $1.2 million in 2026.
• The last three Shares Outstanding figures came in at $1.2 million (Q1 2026), $156000.0 (Q4 2025), and $7.8 million (Q3 2025), per Business Quant data.